The clinical studies STEP-4 (semaglutide), SURMOUNT-4 and the 3-year extension of SURMOUNT-1 (tirzepatide), showed that as long as GBT is maintained, weight loss is likely to be maintained, whereas patients who discontinued the GBT treatment regained around two-thirds of their weight loss within one year [16,[147], [148], [149]]
Natalie Mayslich, Chief Operating Officer of ISSA, captures the urgency clearly, The weight loss landscape is changing dramatically, and trainers and coaches need more than sciencethey need strategies to best help their clients succeed. Beyond the Prescription: Coaching for Sustainable Change GLP-1s are a catalystnot a cure
If you're recovering from an injury, dealing with chronic joint pain, or looking for a way to accelerate healing after surgery, you may have heard about BPC-157
Other international helplines can be found at befrienders.org